Regeneron Pharmaceuticals Inc (REGN)
959.72
-4.75
(-0.49%)
USD |
NASDAQ |
Mar 18, 16:00
958.79
-0.93
(-0.10%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price to Book Value: 4.056 for March 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 18, 2024 | 4.056 |
March 15, 2024 | 4.076 |
March 14, 2024 | 4.053 |
March 13, 2024 | 4.080 |
March 12, 2024 | 4.102 |
March 11, 2024 | 4.076 |
March 08, 2024 | 4.094 |
March 07, 2024 | 4.113 |
March 06, 2024 | 4.108 |
March 05, 2024 | 4.079 |
March 04, 2024 | 4.104 |
March 01, 2024 | 4.153 |
February 29, 2024 | 4.083 |
February 28, 2024 | 4.174 |
February 27, 2024 | 4.198 |
February 26, 2024 | 4.181 |
February 23, 2024 | 4.146 |
February 22, 2024 | 4.078 |
February 21, 2024 | 4.027 |
February 20, 2024 | 4.002 |
February 16, 2024 | 4.006 |
February 15, 2024 | 4.035 |
February 14, 2024 | 4.006 |
February 13, 2024 | 3.974 |
February 12, 2024 | 4.002 |
Date | Value |
---|---|
February 09, 2024 | 4.029 |
February 08, 2024 | 4.000 |
February 07, 2024 | 3.966 |
February 06, 2024 | 3.963 |
February 05, 2024 | 3.957 |
February 02, 2024 | 3.994 |
February 01, 2024 | 4.048 |
January 31, 2024 | 3.984 |
January 30, 2024 | 4.056 |
January 29, 2024 | 4.039 |
January 26, 2024 | 3.973 |
January 25, 2024 | 4.010 |
January 24, 2024 | 3.995 |
January 23, 2024 | 4.021 |
January 22, 2024 | 3.972 |
January 19, 2024 | 3.932 |
January 18, 2024 | 3.918 |
January 17, 2024 | 3.914 |
January 16, 2024 | 3.949 |
January 12, 2024 | 3.931 |
January 11, 2024 | 3.859 |
January 10, 2024 | 3.817 |
January 09, 2024 | 3.803 |
January 08, 2024 | 3.804 |
January 05, 2024 | 3.847 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.863
Minimum
Oct 02 2019
7.705
Maximum
Jul 20 2020
4.151
Average
3.814
Median
Oct 28 2022
Price to Book Value Benchmarks
Eli Lilly and Co | 67.27 |
Vertex Pharmaceuticals Inc | 6.040 |
Pfizer Inc | 1.758 |
AbbVie Inc | 30.43 |
Puma Biotechnology Inc | 4.194 |
Price to Book Value Related Metrics
PE Ratio | 27.62 |
PS Ratio | 8.322 |
Price to Free Cash Flow | 29.77 |
Price | 959.72 |
Earnings Yield | 3.62% |
Market Cap | 105.34B |
Operating PE Ratio | 25.79 |
Normalized PE Ratio | 25.04 |